249 related articles for article (PubMed ID: 15264222)
1. Interplay among platelet-activating factor, oxidative stress, and group I metabotropic glutamate receptors modulates neuronal survival.
Zhu P; DeCoster MA; Bazan NG
J Neurosci Res; 2004 Aug; 77(4):525-31. PubMed ID: 15264222
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the NMDA receptor/nitric oxide signal pathway in platelet-activating factor-induced neurotoxicity.
Xu Y; Tao YX
Neuroreport; 2004 Feb; 15(2):263-6. PubMed ID: 15076749
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3.
Hostettler ME; Knapp PE; Carlson SL
Glia; 2002 May; 38(3):228-39. PubMed ID: 11968060
[TBL] [Abstract][Full Text] [Related]
4. The metabotropic glutamate system promotes neuronal survival through distinct pathways of programmed cell death.
Vincent AM; Maiese K
Exp Neurol; 2000 Nov; 166(1):65-82. PubMed ID: 11031084
[TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor is a downstream messenger of kainate-induced activation of mitogen-activated protein kinases in primary hippocampal neurons.
DeCoster MA; Mukherjee PK; Davis RJ; Bazan NG
J Neurosci Res; 1998 Aug; 53(3):297-303. PubMed ID: 9698157
[TBL] [Abstract][Full Text] [Related]
6. Neuronal damage by secretory phospholipase A2: modulation by cytosolic phospholipase A2, platelet-activating factor, and cyclooxygenase-2 in neuronal cells in culture.
Kolko M; Rodriguez de Turco EB; Diemer NH; Bazan NG
Neurosci Lett; 2003 Feb; 338(2):164-8. PubMed ID: 12566178
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of hippocampal LTP by ginkgolide B is mediated by its blocking action on PAF rather than glycine receptors.
Kondratskaya EL; Pankratov YV; Lalo UV; Chatterjee SS; Krishtal OA
Neurochem Int; 2004 Feb; 44(3):171-7. PubMed ID: 14568560
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy.
Beauchamp MH; Marrache AM; Hou X; Gobeil F; Bernier SG; Lachapelle P; Abran D; Quiniou C; Brault S; Peri KG; Roberts J; Almazan G; Varma DR; Chemtob S
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3327-37. PubMed ID: 12356842
[TBL] [Abstract][Full Text] [Related]
9. Blood-brain barrier breakdown by PAF and protection by XQ-1H due to antagonism of PAF effects.
Deng Y; Fang W; Li Y; Cen J; Fang F; Lv P; Gong S; Mao L
Eur J Pharmacol; 2009 Aug; 616(1-3):43-7. PubMed ID: 19555682
[TBL] [Abstract][Full Text] [Related]
10. Influence of metabotropic glutamate receptor agonists on the inhibitory effects of adenosine A1 receptor activation in the rat hippocampus.
de Mendonça A; Ribeiro JA
Br J Pharmacol; 1997 Aug; 121(8):1541-8. PubMed ID: 9283686
[TBL] [Abstract][Full Text] [Related]
11. Involvement of platelet-activating factor (PAF) in glutamate neurotoxicity in rat neuronal cultures.
Nogami K; Hirashima Y; Endo S; Takaku A
Brain Res; 1997 Apr; 754(1-2):72-8. PubMed ID: 9134961
[TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor and antagonists modulate DNA synthesis in human bone marrow stromal cell cultures.
Rougier F; Dupuis F; Cornu E; Dulery C; Praloran V; Denizot Y
J Lipid Mediat Cell Signal; 1997 Jul; 16(3):147-53. PubMed ID: 9246604
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of natural polyphenols on neuronal survival in primary cultured central neurons against glutamate- and glucose deprivation-induced neuronal death.
Lee HH; Yang LL; Wang CC; Hu SY; Chang SF; Lee YH
Brain Res; 2003 Oct; 986(1-2):103-13. PubMed ID: 12965234
[TBL] [Abstract][Full Text] [Related]
14. Preparation of 7-substituted ginkgolide derivatives: potent platelet activating factor (PAF) receptor antagonists.
Vogensen SB; Strømgaard K; Shindou H; Jaracz S; Suehiro M; Ishii S; Shimizu T; Nakanishi K
J Med Chem; 2003 Feb; 46(4):601-8. PubMed ID: 12570381
[TBL] [Abstract][Full Text] [Related]
15. Effects of platelet-activating factor on arteriolar and venular tone in rat trachea.
Collins LC; Roberts AM
Microvasc Res; 1997 Jan; 53(1):63-72. PubMed ID: 9056476
[TBL] [Abstract][Full Text] [Related]
16. Role of platelet-activating factor in hepatocellular Ca2+ alterations during hemorrhagic shock.
Silomon M; Pizanis A; Larsen R; Rose S
J Surg Res; 1997 Oct; 72(2):101-6. PubMed ID: 9356229
[TBL] [Abstract][Full Text] [Related]
17. The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C.
Bastianetto S; Zheng WH; Quirion R
J Neurochem; 2000 Jun; 74(6):2268-77. PubMed ID: 10820186
[TBL] [Abstract][Full Text] [Related]
18. Effect of platelet-activating factor (PAF) receptor antagonist (BN52021) on acetaminophen-induced acute liver injury and regeneration in rats.
Grypioti AD; Theocharis SE; Demopoulos CA; Papadopoulou-Daifoti Z; Basayiannis AC; Mykoniatis MG
Liver Int; 2006 Feb; 26(1):97-105. PubMed ID: 16420515
[TBL] [Abstract][Full Text] [Related]
19. Platelet activating factor-induced neuronal apoptosis is initiated independently of its G-protein coupled PAF receptor and is inhibited by the benzoate orsellinic acid.
Ryan SD; Harris CS; Mo F; Lee H; Hou ST; Bazan NG; Haddad PS; Arnason JT; Bennett SA
J Neurochem; 2007 Oct; 103(1):88-97. PubMed ID: 17877634
[TBL] [Abstract][Full Text] [Related]
20. [Effect of platelet activating factor receptor at spinal cord neurocyte membrane on secondary damage after spinal cord injury].
Xiao J; Zhao D; Jia L
Zhonghua Yi Xue Za Zhi; 1996 Feb; 76(2):120-3. PubMed ID: 8758444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
